Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 14 | 2024 | 2647 | 1.620 |
Why?
|
Physicians, Primary Care | 4 | 2023 | 623 | 1.500 |
Why?
|
Genetic Testing | 15 | 2024 | 3537 | 1.450 |
Why?
|
Primary Health Care | 11 | 2023 | 4686 | 1.400 |
Why?
|
Diabetes Mellitus, Type 2 | 21 | 2023 | 12148 | 1.300 |
Why?
|
Veterans Health | 3 | 2020 | 215 | 1.290 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2023 | 3245 | 1.210 |
Why?
|
Genotype | 7 | 2021 | 12990 | 1.090 |
Why?
|
Muscular Diseases | 3 | 2020 | 553 | 1.050 |
Why?
|
Coronary Artery Disease | 8 | 2024 | 6403 | 0.990 |
Why?
|
Cholesterol, LDL | 3 | 2024 | 2382 | 0.930 |
Why?
|
Pharmacogenetics | 7 | 2022 | 675 | 0.910 |
Why?
|
Prostatic Neoplasms | 7 | 2024 | 11118 | 0.710 |
Why?
|
Genomics | 9 | 2019 | 5821 | 0.660 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2024 | 395 | 0.640 |
Why?
|
Genetic Counseling | 4 | 2024 | 627 | 0.630 |
Why?
|
Atherosclerosis | 5 | 2023 | 3408 | 0.600 |
Why?
|
Sequence Analysis, DNA | 4 | 2018 | 4740 | 0.600 |
Why?
|
Cardiovascular Diseases | 11 | 2023 | 15500 | 0.590 |
Why?
|
Rheumatology | 1 | 2024 | 615 | 0.580 |
Why?
|
United States Department of Veterans Affairs | 7 | 2022 | 928 | 0.570 |
Why?
|
Rheumatic Diseases | 1 | 2024 | 649 | 0.550 |
Why?
|
Genome, Human | 5 | 2017 | 4425 | 0.530 |
Why?
|
Early Detection of Cancer | 5 | 2024 | 3201 | 0.530 |
Why?
|
Simvastatin | 1 | 2018 | 346 | 0.530 |
Why?
|
Medical History Taking | 2 | 2017 | 774 | 0.510 |
Why?
|
Genetic Predisposition to Disease | 11 | 2024 | 17904 | 0.500 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2018 | 246 | 0.500 |
Why?
|
Patient Education as Topic | 2 | 2024 | 2319 | 0.500 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2020 | 15936 | 0.480 |
Why?
|
Epidemiologic Research Design | 1 | 2018 | 368 | 0.460 |
Why?
|
Sequence Analysis | 1 | 2015 | 240 | 0.460 |
Why?
|
Attitude of Health Personnel | 3 | 2018 | 3889 | 0.450 |
Why?
|
Fasting | 1 | 2020 | 1603 | 0.450 |
Why?
|
Physicians | 3 | 2023 | 4591 | 0.410 |
Why?
|
Research Design | 3 | 2019 | 6180 | 0.410 |
Why?
|
Research Report | 2 | 2016 | 367 | 0.410 |
Why?
|
Risk Factors | 26 | 2024 | 74206 | 0.390 |
Why?
|
Calcium | 2 | 2024 | 5722 | 0.370 |
Why?
|
Humans | 86 | 2024 | 761504 | 0.360 |
Why?
|
Risk Assessment | 13 | 2024 | 23995 | 0.360 |
Why?
|
Medical Informatics | 1 | 2018 | 733 | 0.360 |
Why?
|
Insulin Resistance | 2 | 2014 | 3963 | 0.350 |
Why?
|
Blood Glucose | 4 | 2020 | 6391 | 0.340 |
Why?
|
Male | 51 | 2024 | 360804 | 0.330 |
Why?
|
Medication Adherence | 1 | 2020 | 2176 | 0.320 |
Why?
|
Cholesterol | 4 | 2023 | 2904 | 0.320 |
Why?
|
Quantitative Trait, Heritable | 1 | 2011 | 543 | 0.310 |
Why?
|
Myocardial Infarction | 3 | 2024 | 11460 | 0.300 |
Why?
|
United States | 27 | 2024 | 72334 | 0.290 |
Why?
|
Middle Aged | 34 | 2024 | 220895 | 0.290 |
Why?
|
Decision Making | 5 | 2018 | 3929 | 0.270 |
Why?
|
Health Literacy | 1 | 2012 | 444 | 0.270 |
Why?
|
Female | 43 | 2024 | 392644 | 0.260 |
Why?
|
Prostate-Specific Antigen | 3 | 2024 | 2469 | 0.250 |
Why?
|
Health Behavior | 2 | 2017 | 2643 | 0.240 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3249 | 0.230 |
Why?
|
Adult | 28 | 2024 | 221177 | 0.230 |
Why?
|
Electronic Health Records | 2 | 2020 | 4811 | 0.230 |
Why?
|
Obesity | 4 | 2016 | 12947 | 0.230 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5127 | 0.220 |
Why?
|
Pilot Projects | 4 | 2024 | 8631 | 0.220 |
Why?
|
Incidental Findings | 2 | 2018 | 697 | 0.210 |
Why?
|
Diabetes Mellitus | 4 | 2019 | 5840 | 0.200 |
Why?
|
Aged | 25 | 2024 | 169289 | 0.200 |
Why?
|
Cardiomyopathies | 1 | 2014 | 1964 | 0.200 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2735 | 0.200 |
Why?
|
Receptors, LDL | 1 | 2024 | 488 | 0.190 |
Why?
|
Stroke | 2 | 2023 | 9757 | 0.190 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 10209 | 0.180 |
Why?
|
Models, Theoretical | 1 | 2012 | 3575 | 0.180 |
Why?
|
Kidney Failure, Chronic | 1 | 2012 | 2471 | 0.170 |
Why?
|
Primary Prevention | 3 | 2018 | 1186 | 0.170 |
Why?
|
Inappropriate Prescribing | 1 | 2022 | 211 | 0.170 |
Why?
|
Duty to Recontact | 1 | 2019 | 19 | 0.170 |
Why?
|
Chromosome Mapping | 2 | 2018 | 4615 | 0.170 |
Why?
|
BRCA2 Protein | 1 | 2024 | 805 | 0.170 |
Why?
|
Duty to Warn | 1 | 2019 | 30 | 0.160 |
Why?
|
Cohort Studies | 8 | 2024 | 41487 | 0.160 |
Why?
|
Feasibility Studies | 2 | 2020 | 5247 | 0.160 |
Why?
|
Genome-Wide Association Study | 5 | 2022 | 12690 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2018 | 4016 | 0.160 |
Why?
|
Eligibility Determination | 1 | 2022 | 421 | 0.160 |
Why?
|
Health Plan Implementation | 1 | 2021 | 337 | 0.160 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2018 | 107 | 0.150 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2019 | 224 | 0.150 |
Why?
|
Patient Preference | 2 | 2017 | 924 | 0.150 |
Why?
|
BRCA1 Protein | 1 | 2024 | 1155 | 0.150 |
Why?
|
Dietary Supplements | 4 | 2019 | 3415 | 0.150 |
Why?
|
Drug Interactions | 1 | 2022 | 1416 | 0.150 |
Why?
|
Parents | 1 | 2011 | 3563 | 0.140 |
Why?
|
Cooking | 1 | 2019 | 315 | 0.140 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2018 | 210 | 0.140 |
Why?
|
Neoplasms | 3 | 2024 | 22170 | 0.140 |
Why?
|
Genetics, Medical | 1 | 2019 | 334 | 0.130 |
Why?
|
Seafood | 1 | 2019 | 393 | 0.130 |
Why?
|
Diabetes Complications | 3 | 2019 | 1315 | 0.130 |
Why?
|
Minerals | 2 | 2007 | 283 | 0.120 |
Why?
|
Disclosure | 2 | 2018 | 748 | 0.120 |
Why?
|
Choice Behavior | 1 | 2020 | 824 | 0.120 |
Why?
|
Ankle Brachial Index | 2 | 2012 | 163 | 0.120 |
Why?
|
Program Development | 1 | 2021 | 1297 | 0.120 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12463 | 0.110 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 588 | 0.110 |
Why?
|
Vitamins | 3 | 2007 | 1635 | 0.110 |
Why?
|
Access to Information | 1 | 2017 | 316 | 0.110 |
Why?
|
Mass Screening | 4 | 2024 | 5428 | 0.100 |
Why?
|
Genetic Loci | 2 | 2020 | 2632 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2018 | 1475 | 0.100 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2012 | 152 | 0.100 |
Why?
|
Health Personnel | 2 | 2023 | 3335 | 0.100 |
Why?
|
Inservice Training | 1 | 2014 | 375 | 0.100 |
Why?
|
Informed Consent | 1 | 2018 | 1008 | 0.090 |
Why?
|
Psychiatry | 1 | 2023 | 1693 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39106 | 0.090 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2897 | 0.090 |
Why?
|
Risk | 2 | 2020 | 9610 | 0.090 |
Why?
|
Finland | 1 | 2011 | 607 | 0.080 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2024 | 0.080 |
Why?
|
Predictive Value of Tests | 4 | 2014 | 15266 | 0.080 |
Why?
|
Life Style | 2 | 2012 | 3917 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 2018 | 1213 | 0.080 |
Why?
|
Incidence | 4 | 2021 | 21353 | 0.080 |
Why?
|
Genome | 1 | 2018 | 1740 | 0.080 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2019 | 1390 | 0.080 |
Why?
|
Prescription Drugs | 1 | 2016 | 631 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2024 | 7390 | 0.080 |
Why?
|
Coronary Disease | 1 | 2023 | 5914 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.080 |
Why?
|
Blood Pressure | 3 | 2022 | 8481 | 0.080 |
Why?
|
Subcutaneous Fat | 1 | 2012 | 393 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3639 | 0.080 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 823 | 0.080 |
Why?
|
Motivation | 3 | 2015 | 2006 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2598 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2020 | 3600 | 0.080 |
Why?
|
Gene Frequency | 2 | 2012 | 3606 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9326 | 0.070 |
Why?
|
Health Care Costs | 2 | 2018 | 3242 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5890 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 488 | 0.070 |
Why?
|
Smoking | 1 | 2024 | 9053 | 0.070 |
Why?
|
Nutrition Surveys | 2 | 2012 | 1733 | 0.070 |
Why?
|
Young Adult | 7 | 2021 | 59243 | 0.070 |
Why?
|
Metabolome | 1 | 2014 | 989 | 0.070 |
Why?
|
Chronic Disease | 3 | 2007 | 9318 | 0.070 |
Why?
|
Cholesterol, HDL | 2 | 2024 | 1814 | 0.070 |
Why?
|
Intra-Abdominal Fat | 1 | 2012 | 613 | 0.070 |
Why?
|
Family Health | 1 | 2012 | 1257 | 0.070 |
Why?
|
Diabetic Neuropathies | 1 | 2010 | 405 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8002 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2024 | 80636 | 0.070 |
Why?
|
Information Dissemination | 1 | 2014 | 1126 | 0.070 |
Why?
|
Delivery of Health Care | 1 | 2024 | 5336 | 0.070 |
Why?
|
Prospective Studies | 5 | 2023 | 54425 | 0.060 |
Why?
|
Research Subjects | 2 | 2019 | 249 | 0.060 |
Why?
|
Models, Statistical | 1 | 2020 | 5079 | 0.060 |
Why?
|
Cause of Death | 3 | 2022 | 3683 | 0.060 |
Why?
|
Public Health | 1 | 2019 | 2669 | 0.060 |
Why?
|
Diet | 2 | 2024 | 8075 | 0.060 |
Why?
|
Hypoglycemic Agents | 2 | 2008 | 3085 | 0.060 |
Why?
|
Prognosis | 3 | 2019 | 29625 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5492 | 0.060 |
Why?
|
Adolescent | 4 | 2014 | 88319 | 0.060 |
Why?
|
Trace Elements | 1 | 2006 | 195 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4761 | 0.060 |
Why?
|
Overweight | 2 | 2012 | 2417 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2013 | 1421 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3205 | 0.050 |
Why?
|
Kidney | 1 | 2018 | 7048 | 0.050 |
Why?
|
Mental Disorders | 1 | 2023 | 6845 | 0.050 |
Why?
|
Body Composition | 1 | 2012 | 2426 | 0.050 |
Why?
|
Breast Neoplasms, Male | 1 | 2024 | 219 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
Genetic Variation | 2 | 2014 | 6567 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26125 | 0.050 |
Why?
|
Ethics Committees, Research | 1 | 2023 | 196 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1998 | 0.050 |
Why?
|
Prevalence | 3 | 2018 | 15732 | 0.050 |
Why?
|
Diabetic Retinopathy | 1 | 2010 | 1274 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14605 | 0.050 |
Why?
|
Curriculum | 1 | 2014 | 3743 | 0.040 |
Why?
|
Alleles | 1 | 2011 | 6863 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8540 | 0.040 |
Why?
|
Phenotype | 2 | 2014 | 16591 | 0.040 |
Why?
|
Body Mass Index | 3 | 2024 | 12953 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2014 | 4486 | 0.040 |
Why?
|
Age Factors | 2 | 2014 | 18395 | 0.040 |
Why?
|
Research Personnel | 1 | 2023 | 588 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4792 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2020 | 616 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7827 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58976 | 0.040 |
Why?
|
Ethics, Research | 1 | 2019 | 176 | 0.040 |
Why?
|
Liability, Legal | 1 | 2019 | 210 | 0.040 |
Why?
|
Self Report | 2 | 2019 | 3724 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 851 | 0.040 |
Why?
|
Classification | 1 | 2017 | 127 | 0.030 |
Why?
|
Remission Induction | 1 | 2022 | 2396 | 0.030 |
Why?
|
Cardiology | 2 | 2018 | 1656 | 0.030 |
Why?
|
Teaching Rounds | 1 | 2020 | 275 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2024 | 1858 | 0.030 |
Why?
|
Genetic Research | 1 | 2017 | 171 | 0.030 |
Why?
|
Intention | 1 | 2018 | 347 | 0.030 |
Why?
|
Australia | 1 | 2019 | 1250 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 935 | 0.030 |
Why?
|
Odds Ratio | 2 | 2019 | 9646 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2122 | 0.030 |
Why?
|
Linear Models | 2 | 2015 | 5871 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2176 | 0.030 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3688 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1913 | 0.030 |
Why?
|
Biopsy | 1 | 2024 | 6766 | 0.020 |
Why?
|
Europe | 1 | 2019 | 3422 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2016 | 793 | 0.020 |
Why?
|
Patients | 1 | 2018 | 907 | 0.020 |
Why?
|
Attitude | 1 | 2017 | 775 | 0.020 |
Why?
|
Uncertainty | 1 | 2017 | 754 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21012 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3579 | 0.020 |
Why?
|
Mexican Americans | 1 | 2012 | 167 | 0.020 |
Why?
|
Thigh | 1 | 2012 | 241 | 0.020 |
Why?
|
Child, Preschool | 1 | 2014 | 42230 | 0.020 |
Why?
|
Area Under Curve | 1 | 2014 | 1638 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2901 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2022 | 64680 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.020 |
Why?
|
Child | 2 | 2014 | 80153 | 0.020 |
Why?
|
Piperazines | 1 | 2019 | 2523 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2010 | 1178 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1998 | 0.020 |
Why?
|
Pyridines | 1 | 2019 | 2875 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3905 | 0.020 |
Why?
|
Adiponectin | 1 | 2012 | 1113 | 0.020 |
Why?
|
Consumer Product Safety | 1 | 2007 | 122 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2012 | 1738 | 0.020 |
Why?
|
Qualitative Research | 1 | 2017 | 3023 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12725 | 0.010 |
Why?
|
beta Carotene | 1 | 2006 | 523 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2016 | 2882 | 0.010 |
Why?
|
Diabetes, Gestational | 1 | 2014 | 1248 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14666 | 0.010 |
Why?
|
Vitamin B Complex | 1 | 2006 | 299 | 0.010 |
Why?
|
India | 1 | 2010 | 2348 | 0.010 |
Why?
|
Selenium | 1 | 2006 | 417 | 0.010 |
Why?
|
Vitamin A | 1 | 2006 | 613 | 0.010 |
Why?
|
Computational Biology | 1 | 2014 | 3518 | 0.010 |
Why?
|
Diabetic Angiopathies | 1 | 2007 | 803 | 0.010 |
Why?
|
Vitamin E | 1 | 2006 | 872 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20098 | 0.010 |
Why?
|
Software | 1 | 2014 | 4434 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2012 | 3826 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13255 | 0.010 |
Why?
|
Administration, Oral | 1 | 2007 | 4021 | 0.010 |
Why?
|
Folic Acid | 1 | 2006 | 1323 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39967 | 0.010 |
Why?
|
Vitamin D | 1 | 2006 | 3303 | 0.010 |
Why?
|
Pregnancy | 1 | 2014 | 29874 | 0.010 |
Why?
|
Concepts
(260)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(78)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_